Liver Disease Treatment in Turkey

Yes, international patients can be assessed and treated for liver disease at accredited hospitals in Turkey, often at a fraction of UK or US private costs. Liver disease is a broad category, so the right pathway depends entirely on your diagnosis, from viral hepatitis B and C and fatty liver disease (MASLD/NASH) through to cirrhosis and its complications. Unal Cakar is an independent health-tourism facilitator and patient advocate, not a clinic: he arranges your consultation, scans and care with vetted hepatology and gastroenterology teams, and you pay the hospital directly with no outcome promises.

Liver disease treatment is not a single operation but a tailored medical programme delivered by hepatologists and gastroenterologists. It covers conditions such as chronic hepatitis B and C, alcohol-related liver disease, metabolic (non-alcoholic) fatty liver disease and its inflammatory form NASH/MASH, autoimmune and genetic liver conditions, cirrhosis (advanced scarring) and its complications, and primary liver cancer. The first goal is always an accurate diagnosis and a clear picture of how much the liver has been affected.

Care begins with a structured hepatology work-up: detailed history, blood tests (liver function panel, viral hepatitis serology and PCR, autoimmune and metabolic markers, clotting), and imaging such as ultrasound, FibroScan (transient elastography) to measure stiffness and fat, and where needed CT, MRI or MRCP. A liver biopsy is only used when imaging and bloods cannot answer the question. Treatment then follows the diagnosis: oral antivirals for hepatitis B, direct-acting antiviral courses for hepatitis C, structured metabolic and lifestyle management for fatty liver, and, for cirrhosis, surveillance plus management of complications such as variceal bleeding (endoscopic banding), fluid build-up and portal hypertension. Selected patients with end-stage disease may be evaluated by a transplant centre, which is assessed entirely on its own clinical and legal criteria.

• Specialist hepatology and gastroenterology work-up: liver bloods, FibroScan, ultrasound and advanced imaging
• Covers viral hepatitis B and C, fatty liver (MASLD/NASH) and compensated cirrhosis, plus second opinions
• Modern direct-acting antivirals for hepatitis C and established oral antivirals for hepatitis B
• Internationally accredited hospitals; independent facilitator, you pay the clinic directly
• Honest candidacy screening before travel and structured monitoring once you are home

1. 01

   Remote review

   You share your diagnosis, recent blood results, scans and medication list. Unal forwards them to the relevant hepatology team for an honest opinion on whether travel and treatment are appropriate.

2. 02

   Plan and quote

   The hospital proposes a work-up and treatment plan with a written, itemised quote. You decide with no pressure, and you pay the clinic directly.

3. 03

   On-site assessment

   On arrival you complete tests such as FibroScan, ultrasound and the relevant bloods so the specialist can confirm the diagnosis and stage before committing to therapy.

4. 04

   Treatment

   You begin the agreed pathway, whether that is starting antivirals, an endoscopic procedure, or a structured metabolic programme, with the plan explained in your own language.

5. 05

   Structured follow-up

   You leave with a clear monitoring schedule. Unal keeps a line of contact open and helps coordinate repeat bloods or scans with your doctor at home.

Stable patients with chronic hepatitis B or C, fatty liver disease, well-compensated cirrhosis or those simply seeking an expert second opinion and clear staging are usually well suited to assessment in Turkey. You are not a good candidate for elective travel if you have acute liver failure, decompensated cirrhosis with active complications (uncontrolled bleeding, severe jaundice, confusion/encephalopathy or large-volume ascites), or any unstable condition that makes flying unsafe; these need urgent care where you are. Liver transplantation is a separate pathway with strict medical, donor and legal requirements and is never something that can be promised in advance. Every plan is confirmed by the treating specialist, who may decline if travel is not in your interest.

• Full hepatology work-up (bloods, FibroScan, imaging) often completed within a few days rather than over months of waiting lists
• Modern direct-acting antiviral regimens for hepatitis C and well-established oral antivirals for hepatitis B
• Significantly lower self-pay costs than UK or US private hepatology for the same investigations and medicines
• Access to high-volume gastroenterology and transplant-experienced centres in one coordinated trip
• An independent advocate who reads your reports, asks the awkward questions and has no incentive to over-treat
• Care explained in English with interpreters, plus help arranging repeat monitoring once you are home

Recovery depends entirely on the diagnosis and the treatment. Many liver conditions are managed with medication and lifestyle change rather than surgery, so there is no downtime at all beyond regular monitoring. A hepatitis C course is typically taken as daily tablets over several weeks with cure confirmed by a blood test about twelve weeks after finishing, while hepatitis B antivirals are usually long-term. Endoscopic procedures such as variceal banding involve only a short observation period.

What all pathways share is the need for ongoing follow-up: repeat liver bloods, periodic FibroScan or ultrasound, and, in cirrhosis, six-monthly surveillance scans. Unal helps you set this monitoring schedule before you fly home and stays reachable so results and any dose changes can be relayed to your local doctor without you feeling abandoned after the trip.

Realistic results vary by condition and cannot be guaranteed. Modern hepatitis C treatment cures the great majority of patients, confirmed only by a sustained negative viral test after treatment. Hepatitis B can usually be well controlled and suppressed with antivirals but is rarely fully eradicated, so treatment is about protecting the liver long term. Early fatty liver disease can improve and even partly reverse with sustained metabolic and lifestyle change, whereas established cirrhosis is generally not reversible and the aim becomes slowing progression and preventing complications. Your specialist will give you an honest, individual prognosis based on your staging rather than a blanket promise.

Turkey combines high-volume, internationally accredited (including JCI) hepatology, gastroenterology and transplant centres with self-pay costs well below UK and US private medicine, particularly for antiviral courses, FibroScan and full diagnostic work-ups. Unal Cakar coordinates this as an independent facilitator and patient advocate, not a hospital: he is sponsored by vetted partner hospitals, so his guidance is free to you, and you only ever pay the clinic directly with no hidden mark-up. His role is to match you to the right specialist, make sure your reports are properly reviewed before you travel, arrange interpreting and logistics, and keep structured aftercare in place once you are home.